Satoshi Iwata
About
In The Last Decade
Satoshi Iwata
294 papers receiving 5.8k citations
Peers
Comparison fields: 5 of 150
- Epidemiology 2.3k
- Molecular Biology 1.4k
- Microbiology 1.1k
- Oncology 1.0k
- Infectious Diseases 727
Countries citing papers authored by Satoshi Iwata
This map shows the geographic impact of Satoshi Iwata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Satoshi Iwata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Satoshi Iwata more than expected).
Fields of papers citing papers by Satoshi Iwata
This network shows the impact of papers produced by Satoshi Iwata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Satoshi Iwata. The network helps show where Satoshi Iwata may publish in the future.
Co-authorship network of co-authors of Satoshi Iwata
This figure shows the co-authorship network connecting the top 25 collaborators of Satoshi Iwata. A scholar is included among the top collaborators of Satoshi Iwata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Satoshi Iwata. Satoshi Iwata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 12 | |
| 2 | 9 | |
| 3 | 42 | |
| 4 | 40 | |
| 5 | 4 | |
| 6 | 2 | |
| 7 | Population pharmacokinetics and pharmacodynamics of tosufloxacin granules in pediatric infectious diseases | 4 |
| 8 | An open clinical study of tebipenem pivoxil in children with acute otitis media and acute upper respiratory tract infection (phase II) | 1 |
| 9 | An open clinical study of tebipenem pivoxil in children with bacterial pneumonia | 3 |
| 10 | Survey on once-daily therapy with ceftriaxone for pediatric bacterial infections | 1 |
| 11 | 87 | |
| 12 | Epidemiology of Streptococcus pneumoniae isolates from patients with meningitis between 1993 and 2002 | 2 |
| 13 | A mouse model of Escherichia coli .O157: H7 infection for evaluation of antibacterial drugs - In vivo release of verotoxins and toxic effect on mice | 3 |
| 14 | [Efficacy of combination therapy against MRSA in Ibaraki Prefecture]. | 4 |
| 15 | [Pharmacokinetic, bacteriological and clinical studies on cefpodoxime proxetil in the field of pediatrics]. | 1 |
| 16 | [Pharmacokinetic and bacteriological studies on sulbactam/ampicillin in the field of pediatrics]. | 2 |
| 17 | From the Teacher to the Top. | 2 |
| 18 | Fundamental And Clinical Evaluation of 9,3”-Diacetylmidecamycin in Pediatric Field | 1 |
| 19 | 1 | |
| 20 | Studies on Giardiasis. | 2 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.